| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8729741 | Journal of Hepatology | 2017 | 55 Pages |
Abstract
This article serves to discuss how HBV genotypes and genetic variants impact not only upon the disease course and outcomes, but also current treatment strategies. Adopting a personalised genotypic approach may play a role in future strategies to combat the disease. Herein, we discuss new technologies that may allow more informed decision-making for response guided therapy in the battle against HBV.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Neil Rajoriya, Christophe Combet, Fabien Zoulim, Harry L.A. Janssen,